13F Pro

SEC Form 4 reporting owner

Goff Brian

Goff Brian has filed 19 Form 4 transactions reported between December 30, 2025 and June 18, 2026, as Chief Executive Officer of AGIOS PHARMACEUTICALS, INC. and a reporting owner of Intellia Therapeutics, Inc..

Name as filed: Goff Brian

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$1.7M
7 lines
Companies
2
with Form 4 filings
Latest transaction
Jun 18, 2026
transaction date

Roles and reported holdings

  • AGIOAGIOS PHARMACEUTICALS, INC.
    Dec 30, 2025 – Jun 18, 2026

    Chief Executive Officer

    Held directly184,508 sh as of Apr 2, 2026 · Form 4

    24 months: $1.7M sold

  • NTLAIntellia Therapeutics, Inc.
    Jun 9, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 19 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jun 18, 2026AGIOChief Executive OfficerOption exerciseCode M · direct39,000—Form 4
Jun 9, 2026NTLAGrant or awardCode A · direct13,300—Form 4
Jun 9, 2026NTLAGrant or awardCode A · direct9,200—Form 4
Apr 2, 2026AGIOChief Executive OfficerOpen-market saleCode S · direct6,596$229K@ $34.71Form 4
Apr 2, 2026AGIOChief Executive OfficerOption exerciseCode M · direct13,500—Form 4
Apr 2, 2026AGIOChief Executive OfficerOpen-market saleCode S · direct12,472$433K@ $34.71Form 4
Apr 2, 2026AGIOChief Executive OfficerOption exerciseCode M · direct25,528—Form 4
Mar 2, 2026AGIOChief Executive OfficerOpen-market saleCode S · direct5,918$171K@ $28.96Form 4
Mar 2, 2026AGIOChief Executive OfficerOption exerciseCode M · direct13,000—Form 4
Mar 2, 2026AGIOChief Executive OfficerOpen-market saleCode S · direct8,267$239K@ $28.96Form 4
Mar 2, 2026AGIOChief Executive OfficerOption exerciseCode M · direct18,000—Form 4
Mar 2, 2026AGIOChief Executive OfficerOpen-market saleCode S · direct3,870$112K@ $28.96Form 4
Mar 2, 2026AGIOChief Executive OfficerOption exerciseCode M · direct8,500—Form 4
Mar 1, 2026AGIOChief Executive OfficerGrant or awardCode A · direct174,000—Form 4
Mar 1, 2026AGIOChief Executive OfficerGrant or awardCode A · direct48,000—Form 4
Dec 30, 2025AGIOChief Executive OfficerOpen-market saleCode S · direct6,230$169K@ $27.09Form 4
Dec 30, 2025AGIOChief Executive OfficerOption exerciseCode M · direct12,750—Form 4
Dec 30, 2025AGIOChief Executive OfficerOpen-market saleCode S · direct12,473$338K@ $27.09Form 4
Dec 30, 2025AGIOChief Executive OfficerOption exerciseCode M · direct25,528—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.